News

Deal Announcements

KineMed Raises New Venture Capital Equity

Tuesday, June 30, 2015 5:45:00 AM PDT | VentureDeal
   Emeryville, California  --  Pharmaceutical technology company KineMed has received $1.7 million in new venture investment, according to an SEC regulatory filing.

KineMed has developed a proprietary translational medicine technology that helps identify active drug candidates and confirm their therapeutic activity.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

KineMed is still seeking $10.8 million in additional financing, according to the filing.

(Not an offer or solicitation for sale of securities.)

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1